About FDA

Percentage of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative (1)

Dictionary: Patient Representatives participate in advisory committee meetings to ensure patient input on important medical product review and policy questions.

The Patient Representative’s role is to provide the advisory committee and FDA insight on issues, problems, and/or questions pertinent to the unique viewpoint of patients living with a specific disease.

• FY 2010
• FY 2011
• FY 2012
• All

Footnotes

• (1) This measure will no longer be tracked after April 2012.

Number of FDA advisory committee meetings during the month that had a Patient Representative (1)

Fiscal Year - 2012

Time	Target	Number
Oct 2011	N/A	3
Nov 2011	N/A	8
Dec 2011	N/A	6
Jan 2012	N/A	2
Feb 2012	N/A	8
Mar 2012	N/A	6
Apr 2012	N/A	5

FY 2012 Oct-Apr Total: 38

Number of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative (1)

Fiscal Year - 2012

Time	Target	Number
Oct 2011	N/A	3
Nov 2011	N/A	9
Dec 2011	N/A	7
Jan 2012	N/A	3
Feb 2012	N/A	8
Mar 2012	N/A	6
Apr 2012	N/A	5

FY 2012 Oct-Apr Total: 41

Total number of advisory committee meetings during the month (1)